|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| A61K 31/713 | |||
| A61K 31/00 | |||
| A61K 45/06 | |||
| A61K 39/395 | |||
| A61P 31/00 | |||
| A61P 35/00 | |||
| A61P 37/04 |
| (11) | Number of the document | 3285809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16719655.9 |
| Date of filing the European patent application | 2016-04-15 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/027870 |
| Date | 2016-04-15 |
| (87) | Number | WO 2016/172010 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201562150140 P | 2015-04-20 | US | |
| 201562260917 P | 2015-11-30 | US |
| (72) |
WEBSTER, Kevin, R., US
GOEL, Vikas, US
|
| (73) |
eFFECTOR Therapeutics, Inc.,
11180 Roselle Street, San Diego, California 92121,
US
|
| (54) | INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS |
| INHIBITORS OF IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCER AND INFECTIONS |